Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Warkentin who wrote (524)	3/26/1999 11:11:00 AM
From: Raven McCloud	Read Replies (2) \| Respond to of 2515

Well, we all have a right to our oppinion, Steve. You did make the pt. that is part of my reasoning that now's NOT the time to buy into IMCL. "LIKELY POTENTIAL" I have seen it more often than not that a biotech company with a POTENTIAL cancer cure goes nowhere. Now, with IMCL, they look to have a better chance than most given the data so far. So I'd say their potential is a little better. Still POTENTIAL though; until I see more data and we get closer to approval, I'll trade IMCL.